{"name":"ViGenCell Inc.","slug":"vigencell-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiqwJBVV95cUxNRi05aEdIV0VBTU1ieFpobTNCaVpYQ1R6VHloYzVsVXpUQlltTFE4UzRKQ0R5cmgza0RMS0ltUUJLbTR0RnBaY3hDbWcwaGZxb18weWYteUJSMEUzb0ppbTVrX1NvdTJqQy16VGlVS0dncGg0bDRTSmQtNlNSc2ZTU19kcEdSNERJMXhGdGM2Zm80Ym5YanFvQ2d2YWo1VHJVWE1aS0k2Uzc2eUhKSDJkNWtBWVMwZ0RjWXI5QnFvMEh3aEwyS3hDYXB1amNHYVkzc3RNQ3MzTEpuSzZZbXk4VTBSLVBDNE8wc2xjdDhWZUt4YUhsS3RCd2tzTHRqajYwVE5rWTJydUZWZTJ4Y1JUcDFLbXBrMmlZX3dVR3JFSFJibnJNZmc2ekUzWQ?oc=5","date":"2026-02-16","type":"trial","source":"GlobeNewswire","summary":"IPSC-derived NK Cells Clinical Trial Pipeline Gains - GlobeNewswire","headline":"IPSC-derived NK Cells Clinical Trial Pipeline Gains","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTFA0S0RIZ2JvN1RobGU3UGJacTg2eEFwZWhLaThsNzdtMHRYMGNEdWZnNVYzSXpudUQtU2ZYeS1neTNNUXN2MDYwbkR3Mmd2YjFVR2xmUHpjVkFqbnNuTDVMQlRqWnFycWoxVGVCSldR0gFyQVVfeXFMT0pvd3k0RS1KdVRjeGw1bFdMTE5HY0pmMEhEeHdyZnBsQ0hrLUZfZ2NRdmR3S01iYVR5OGtINURDakNzSUxQSEtRVGZFSGtab0thbXU3b3IxYTJMeDJqS2FUTWpIUHo2RWd4M1NiRkV4eEpB?oc=5","date":"2025-10-02","type":"pipeline","source":"koreabiomed.com","summary":"ViGenCell and Therabest to co-develop new drug for hepatocellular carcinoma - koreabiomed.com","headline":"ViGenCell and Therabest to co-develop new drug for hepatocellular carcinoma","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTFBHc1g0azc3YWxuM2FxUncxQ3dUWDgxVUUtVFRpSnZwNWNJNUxMMWk1T0xnRnpvRlhhc2JIMHExOFRhd1BZYW1xcXpwVXRPYVVtUVM3X202eGtqallhTGNJenFRT1dnMUl4S0N0MUVB?oc=5","date":"2023-12-27","type":"pipeline","source":"KED Global","summary":"ViGenCell, NK/T cell lymphoma treatment ‘VT-EBV-N’ designated as orphan drug in Europe - KED Global","headline":"ViGenCell, NK/T cell lymphoma treatment ‘VT-EBV-N’ designated as orphan drug in Europe","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE93VFVLNnAxcG1MdEw0bndrZXd5SVZRR1hzajZ5Q0hjWi1wZ1JZVThnMEgtRWFmRGxTRUJoZ1VIRjFpalhaU3JFS3pfS2RKZzRKdWI2M2ptdEpPbmNFMllTdHlsTkdDZDNrUTBfY3Jn0gFyQVVfeXFMUEdtZHAzLXI5MW1VV3kyUWJFSHE0QXRIcEZYQWFDamRuam0wNHZGUFVqZTdLM1BnNk9kWGExUVJpQXB1SUlrYkI4cktINFphSWU2T0ZQbVdXWHlHX3VndFlTN04tbGtmMFIweXhTUU9FX193?oc=5","date":"2021-10-27","type":"pipeline","source":"koreabiomed.com","summary":"Korean bio companies expand production capacity to win more CMO works - koreabiomed.com","headline":"Korean bio companies expand production capacity to win more CMO works","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiVkFVX3lxTFBoeWFkeTRIVnpxbEJIUGhxSTZ0UVFlUTAxOU44WEtoYzA0R1VRLURMRDlWREdVZmVBSW9QZTRQZG1SWks1d0I3MmV2bVZ6TW5fWjR5NFFR?oc=5","date":"2020-04-07","type":"trial","source":"바이오스펙테이터","summary":"ViGenCell is expanding cell therapy platforms: it plans to enter clinical trials on two platforms this year - 바이오스펙테이터","headline":"ViGenCell is expanding cell therapy platforms: it plans to enter clinical trials on two platforms this year - 바이오스펙테이터","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":3,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}